Skip to main content

Compugen Ltd

CGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001119774

In the last 90 days, Compugen Ltd insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $30.3M in total; ARK Invest is the only superinvestor holding it.

Q2 2026 vs. Q1 2026

How the institutions holding Compugen Ltd changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of CGEN: Q1 2026 compared with Q2 2026
MeasureQ1 2026Q2 2026Change
Holders7983+4
Shares14.2M14.2M−49.8K (−0.4%)
Value$30.3M$30.3M+$44.9K (+0.1%)

New holders (15)

Institutions that held Compugen Ltd at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to CGEN in Q2 2026
InstitutionSharesValue% of portfolio
American Century Companies Inc213,731$457.4K0.00%
Squarepoint Ops LLC51,320$109.8K0.00%
Invesco Ltd.40,016$85.6K0.00%
Graham Capital Management, L.P.33,398$71.5K0.00%
Prudential Financial Inc24,200$51.8K0.00%
Oppenheimer & Co Inc15,500$33.2K0.00%
Blair William & Co13,600$29.1K0.00%
Point72 Asset Management, L.P.11,901$25.5K0.00%
Bank of America Corp11,068$23.7K0.00%
Two Sigma Securities, LLC10,153$21.7K0.00%
Spire Wealth Management6,564$14.0K0.00%
Barclays PLC2,906$6.22K0.00%
Citigroup Inc1,798$3.85K0.00%
Simplex Trading, LLC1,005$2.15K0.00%
Quarry LP83$1780.00%

Sold out (11)

Institutions that held Compugen Ltd at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of CGEN in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Northern Trust Corp650,868$1.39M
Hillsdale Investment Management Inc.31,730$67.6K
Calamos Advisors LLC29,500$62.8K
Magnolia Capital Advisors LLC25,000$53.3K
HRT Financial LP25,163$53.0K
Bank Hapoalim BM24,000$51.0K
R Squared Ltd13,445$28.6K
Qube Research & Technologies Ltd12,197$26.0K
JPMorgan Chase & Co2,070$4.12K
Sound Income Strategies, LLC500$1.10K
Jones Financial Companies LLLP200$408